A business in context
RVMD research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-08 | Kim Lorence H. | S · Sale | Common Stock | 4730.0 | 210.5 |
| 2026-09-08 | Kim Lorence H. | S · Sale | Common Stock | 3844.0 | 211.36 |
| 2026-09-08 | Kim Lorence H. | S · Sale | Common Stock | 2853.0 | 209.56 |
| 2026-08-31 | Kim Lorence H. | S · Sale | Common Stock | 625.0 | 206.15 |
| 2026-08-31 | Kim Lorence H. | S · Sale | Common Stock | 300.0 | 200.56 |
| 2026-08-31 | Kim Lorence H. | S · Sale | Common Stock | 6597.0 | 201.47 |
| 2026-08-31 | Kim Lorence H. | S · Sale | Common Stock | 26160.0 | 203.55 |
| 2026-08-31 | Kim Lorence H. | S · Sale | Common Stock | 7271.0 | 204.35 |
| 2026-08-31 | Kim Lorence H. | S · Sale | Common Stock | 12919.0 | 202.48 |
| 2026-08-31 | Kim Lorence H. | S · Sale | Common Stock | 2128.0 | 205.19 |
| 2026-08-21 | Cislini Jeff | M · Exercise / conversion | Common Stock | 29680.0 | 18.56 |
| 2026-08-21 | Cislini Jeff | S · Sale | Common Stock | 2540.0 | 210.26 |
| 2026-08-21 | Cislini Jeff | S · Sale | Common Stock | 3314.0 | 212.06 |
| 2026-08-21 | Cislini Jeff | S · Sale | Common Stock | 4500.0 | 211.34 |
| 2026-08-21 | Cislini Jeff | S · Sale | Common Stock | 3400.0 | 207.24 |
| 2026-08-21 | Cislini Jeff | S · Sale | Common Stock | 25817.0 | 209.25 |
| 2026-08-21 | Cislini Jeff | S · Sale | Common Stock | 17323.0 | 208.37 |
| 2026-08-21 | Cislini Jeff | M · Exercise / conversion | Common Stock | 26600.0 | 21.61 |
| 2026-08-21 | Cislini Jeff | M · Exercise / conversion | Stock Option (Right to Buy) | 29680.0 | 0.0 |
| 2026-08-21 | Cislini Jeff | M · Exercise / conversion | Stock Option (Right to Buy) | 26600.0 | 0.0 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 245.0 | 211.47 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 229.0 | 211.46 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 126.0 | 210.4 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 1405.0 | 209.27 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 937.0 | 208.36 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 177.0 | 207.25 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 127.0 | 212.06 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 126.0 | 212.06 |
| 2026-08-21 | GOLDSMITH MARK A | M · Exercise / conversion | Common Stock | 80000.0 | 4.73 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 5128.0 | 207.23 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 24917.0 | 208.37 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 35938.0 | 209.26 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 3813.0 | 210.25 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 6583.0 | 211.33 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 3621.0 | 212.08 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 190.0 | 207.25 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 951.0 | 208.36 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 1351.0 | 209.28 |
| 2026-08-21 | GOLDSMITH MARK A | S · Sale | Common Stock | 136.0 | 210.4 |
| 2026-08-21 | GOLDSMITH MARK A | M · Exercise / conversion | Stock Option (Right to Buy) | 80000.0 | 0.0 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 300.0 | 183.17 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 900.0 | 184.59 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 1100.0 | 185.9 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 881.0 | 192.61 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 300.0 | 187.83 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 100.0 | 188.57 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 600.0 | 190.55 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 541.0 | 191.87 |
| 2026-06-29 | Patel Sushil | M · Exercise / conversion | Common Stock | 2955.0 | 37.54 |
| 2026-06-29 | Patel Sushil | S · Sale | Common Stock | 858.0 | 186.92 |
Identity & relationships
SEC issuer · 0001628171Revolution Medicines, Inc.
- Legal Entity Identifier
- 549300JU3X0LBCQ65892
- GLEIF legal name
- REVOLUTION MEDICINES, INC.
- Entity / LEI registration status
- ACTIVE / LAPSED
- Reference data updated
- 2026-08-12T14:58:24Z
Search names and former names
View Wikidata identity and references ↗
- Revolution Medicines (United States) · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $0 | $0 |
| 2023-12-31 | $11.58M | $12.80M |
| 2022-12-31 | $35.38M | $40.73M |
| 2021-12-31 | $29.39M | $36.54M |
| 2020-12-31 | $42.98M | $55.96M |
| 2019-12-31 | $50.04M | $65.95M |
| 2018-12-31 | $20.16M | $27.06M |